Of the vaccines at present in Section 3 trials, all are administered by injection. (Representational)

New Delhi:

Serum Institute of India and Bharat Biotech are anticipated to pursue late stage medical trials of intranasal COVID-19 vaccines within the coming months as soon as they obtain regulatory approval, Well being Minister Dr Harsh Vardhan stated right this moment.

Mr Vardhan stated the late-stage trial typically includes 1000’s of individuals, generally 30,000 to 40,000.

Of the vaccines at present in Section 3 trials, all are administered by injection, in line with the World Well being Group (WHO).

On Saturday, Dr Reddy’s Laboratories Ltd and the Russian Direct Funding Fund (RDIF) stated they’ve obtained renewed approval to conduct late-stage medical trials in India of the Russian COVID-19 vaccine.

Coronavirus infections rose by one other 61,871 over the previous 24 hours within the nation, information launched on Sunday confirmed, though the well being ministry stated it’s seeing a development of steadily declining energetic circumstances.

The Indian Council of Medical Analysis (ICMR) stated it’ll revisit its protocol for COVID-19 remedy after the WHO discovered among the generally used medication, together with remdesivir, had little or no influence on a affected person’s probabilities of surviving, studies stated.